Skip to main content
padlock icon - secure page this page is secure

Mechanistic Description of Natural Herbs in the Treatment of Dementia: A Systematic Review

Buy Article:

$68.00 + tax (Refund Policy)

Background: Diverse chronic disease arises with aging including cardiac and neurodegenerative disorders. Oxidative stress is considered to be the important cause of aging which can affect various vital organs and lead to a general reduction in physiological functions. The brain is the most sensitive organ towards such oxidative stress due to high oxygen consumption and higher metabolism. Aging of the brain can impair the cognitive skills and memory which lead to the demented condition. The histopathological hallmarks of dementia are a neuronal loss in the forebrain, generation of amyloid β plaque and neurofibrillary tangles. It eventually abolishes the thinking skill and memory.

Objective: Thus, dementia is a major public health concern, with economic and social burden, of which occurrence is greatly increasing. There is no cure for dementia, however, only a few approved drugs are available for the management of the demented condition. Hence, there is a need of alternative medicine for effective treatment and management.

Method: Nowadays, several herbal products have been introduced with their neuroprotective effects, with additional advantages of being low cost, easily available and with fewer side effects.

Conclusion: This review represented the pathophysiology of dementia, classification with current therapy and advancement in plant products for their potential neuroprotective properties.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Alzheimer's disease; Dementia; amyloid β plaque; cognition; herbal products; mechanistic description; neurofibrillary tangles; neuroprotection

Document Type: Review Article

Publication date: August 1, 2018

More about this publication?
  • Current Psychopharmacology publishes peer-reviewed expert review articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology. Data must be published for the first time in Current Psychopharmacology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more